Comparing two creams for eczema in children and young adults
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial compares two prescription creams, Crisaborole and Tacrolimus, to see which works better for treating atopic dermatitis (eczema) in people aged 5 to 25 with mild to moderate symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be between 5 and 25 years old
- Has been diagnosed with atopic dermatitis (eczema) by a doctor
- The eczema is mild to moderate (not severe)
- Must not have used any eczema creams or pills in the last 14 days, and no oral treatments for eczema in the last month
- Not pregnant or breastfeeding (if female and of childbearing age)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This trial tests a daily pill called Abrocitinib to see if it can help children ages 6 to 11 with moderate-to-severe eczema that hasn't gotten better with creams or ointments. Eczema (also called atopic dermatitis) causes itchy, red skin, and this medicine might calm the immune response to reduce itching and rashes.
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
This Phase 2 study tests different treatments for atopic dermatitis (eczema) by looking at changes in skin health. It may help people find safer, more effective ways to control moderate to severe eczema and related skin infections.
This trial tests if crisaborole ointment works better and is safer than tacrolimus ointment for mild to moderate atopic dermatitis (eczema). It may help you find a new treatment option.
This study compares two prescription creams (tacrolimus and crisaborole) to see which works better and is safer for treating mild to moderate eczema in children and young adults aged 2–20. Both are non-steroid options that may help reduce itching and skin inflammation.
Hear when a new Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.